In Response: We read with interest the comment by Liu et al. (1) to our article reporting overt disease in calves caused by infection with atypical or 'Hobi'-like pestivirus (2) . Although we can rule out that vaccination was the source of infection because only killed vaccines were administered on the farm, the most recent fi ndings about this emerging group of viruses deserves further discussion regarding their possible taxonomical, diagnostic, and prophylactic implications.
The association of 'Hobi'-like pestivirus with clinical disease in cattle was confi rmed by reports of experimental and natural infections (3, 4) . A cytopathogenic/noncytopathogenic 'Hobi'-like virus pair was isolated from a diseased heifer, demonstrating that the new group of viruses includes 2 biotypes already known for bovine viral diarrheal viruses 1 (BVDV-1) and 2 (BVDV-2) (5).
Although the clinical presentation might mimic that of extant BVDV-1/ BVDV-2, distinctive features were also evident in the reported cases (1,4) . At the antigenic and phylogenetic levels, 'Hobi'-like strains showed distinct differences from the other bovine pestiviruses: they were at least as different from BVDV-1/2 as are border disease virus and classical swine fever virus (6; N. Decaro et al., unpub. data). The antigenic and genetic uniqueness of 'Hobi'-like viruses will likely lead to the defi nition of a new species within genus Pestivirus, but how this species should be designated remains unclear.
LETTERS
Some scientists have tentatively proposed to name the virus bovine viral diarrhea 3, but others believe this nomenclature would be problematic from regulatory and scientifi c standpoints (J. Ridpath, pers. comm.). Molecular assays standardized for BVDV-1/2 might not be able to detect 'Hobi'-like strains because of the presence of mismatches in the oligonucleotide binding regions (7) . Prophylactic measures should take into account the circulation of 'Hobi'-like pestiviruses in cattle herds. Whether commercial BVDV vaccines are effective against the emerging pestivirus is unknown, and requires future in vivo cross-protection studies.
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